Altmetric

Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG

File Description SizeFormat 
Reglinski_et_al_acceptedVaccinemanuscript.pdfAccepted version1.38 MBAdobe PDFView/Open
1-s2.0-S0163445316000487-main.pdfPublished version1.04 MBAdobe PDFView/Open
Title: Development of a multicomponent vaccine for Streptococcus pyogenes based on the antigenic targets of IVIG
Authors: Reglinski, M
Lynskey, NN
Choi, YJ
Sriskandan, S
Edwards, RJ
Item Type: Journal Article
Issue Date: 12-Feb-2016
Date of Acceptance: 6-Feb-2016
URI: http://hdl.handle.net/10044/1/29618
DOI: https://dx.doi.org/10.1016/j.jinf.2016.02.002
ISSN: 1532-2742
Publisher: Elsevier
Start Page: 450
End Page: 459
Journal / Book Title: Journal of Infection
Volume: 72
Issue: 4
Copyright Statement: © 2016 The Authors. Published by Elsevier Ltd on behalf of the The British Infection Association. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
Sponsor/Funder: Wellcome Trust
Medical Research Council (MRC)
Imperial College Healthcare NHS Trust- BRC Funding
Medical Research Council (MRC)
Funder's Grant Number: 087732/Z/08/Z
G0800777
RDA02 79560
MC_PC_12015
Keywords: Group A Streptococcus
IVIG
Population immunity
Streptococcus pyogenes
Vaccine
Microbiology
1103 Clinical Sciences
Publication Status: Published
Appears in Collections:Department of Medicine
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx